Targovax ASA: Approval and publication listing prospectus
Reference is made to the stock exchange announcement made on 17 March 2017 regarding Targovax ASA's ("Targovax" or the "Company") resolution to apply for a transfer of the listing of the Company's shares from Oslo Axess to the main list on Oslo Stock Exchange.
The Financial Supervisory Authority of Norway has today approved the listing prospectus (the "Prospectus") prepared by the Company in connection with the listing on the Oslo Stock Exchange. The Prospectus will be available at www.targovax.com from today. Hard copies of the Prospectus may be obtained free of charge by contacting the Company.
For further information, please contact:
Renate Birkeli, Investor Relations
Phone: +47 922 61 624
Email: renate.birkeli@targovax.com
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Targovax ASA via GlobeNewswire
Upcoming Life Sciences Events
- April 2024
- London: BioTrinity 2024
- Singapore: Asia Bio Partnering Forum
- London: LSX World Congress
Latest company news
There are currently no news available for this portal